title: Management of juvenile myasthenia gravis.
abstract: Juvenile myasthenia gravis is an uncommon autoimmune disorder. Its management is not standardized. Juvenile myasthenia gravis is pathophysiologically similar to myasthenia gravis in adults. However, a number of significant particularities related to race, age at onset, severity, and antibody status complicate the management. We summarize the unique clinical features of juvenile myasthenia gravis and review the therapeutic options.
authors: Connecticut Children's Medical Center, Department of Pediatrics, and Division of Pediatric Neurology, Department of Neurology, University of Connecticut School of Medicine, Hartford, CT 06106, USA. cionita@ccmckids.org
authors: Cristian M
authors: CM
authors: Ionita
authors: Gyula
authors: G
authors: Acsadi
mesh_terms: D000293:Adolescent; D017668:Age of Onset; D002648:Child; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D006801:Humans; D007165:Immunosuppression Therapy; D009157:Myasthenia Gravis / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D013934:Thymectomy
chemical_list: D002800:Cholinesterase Inhibitors